WBI Investments’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-3,017
| Closed | -$689K | – | 277 |
|
|
2025
Q4 | $689K | Sell |
3,017
-1,480
| -33% | -$337K | 0.18% | 159 |
|
|
2025
Q3 | $1.04M | Buy |
4,497
+1,610
| +56% | +$328K | 0.27% | 102 |
|
|
2025
Q2 | $536K | Buy |
+2,887
| New | +$537K | 0.14% | 173 |
|
|
2024
Q4 | – | Sell |
-4,125
| Closed | -$815K | – | 200 |
|
|
2024
Q3 | $815K | Buy |
+4,125
| New | +$770K | 0.2% | 116 |
|
|
2024
Q2 | – | Sell |
-8,952
| Closed | -$1.63M | – | 165 |
|
|
2024
Q1 | $1.63M | Sell |
8,952
-2,006
| -18% | -$346K | 0.34% | 77 |
|
|
2023
Q4 | $1.7M | Buy |
+10,958
| New | +$1.6M | 0.34% | 76 |
|
|
2023
Q2 | – | Sell |
-9,897
| Closed | -$1.58M | – | 185 |
|
|
2023
Q1 | $1.58M | Sell |
9,897
-34,119
| -78% | -$5.22M | 0.32% | 86 |
|
|
2022
Q4 | $7.11M | Buy |
+44,016
| New | +$6.75M | 1.52% | 13 |
|
|
2022
Q3 | – | Sell |
-51,285
| Closed | -$7.63M | – | 110 |
|
|
2022
Q2 | $7.63M | Sell |
51,285
-7,698
| -13% | -$1.18M | 1.65% | 17 |
|
|
2022
Q1 | $9.33M | Sell |
58,983
-55,583
| -49% | -$8.07M | 1.51% | 12 |
|
|
2021
Q4 | $15.3M | Buy |
114,566
+84,439
| +280% | +$9.97M | 2.45% | 10 |
|
|
2021
Q3 | $3.17M | Sell |
30,127
-29,969
| -50% | -$3.42M | 0.53% | 48 |
|
|
2021
Q2 | $6.77M | Sell |
60,096
-45,310
| -43% | -$5.1M | 1.04% | 22 |
|
|
2021
Q1 | $11.4M | Buy |
105,406
+85,767
| +437% | +$9.17M | 1.79% | 10 |
|
|
2020
Q4 | $2.1M | Sell |
19,639
-1,979
| -9% | -$190K | 0.32% | 67 |
|
|
2020
Q3 | $1.89M | Buy |
21,618
+178
| +0.8% | +$16.8K | 0.29% | 59 |
|
|
2020
Q2 | $2.1M | Buy |
+21,440
| New | +$1.89M | 0.34% | 42 |
|
|
2020
Q1 | – | Sell |
-150,512
| Closed | -$13.3M | – | 85 |
|
|
2019
Q4 | $13.3M | Sell |
150,512
-3,145
| -2% | -$261K | 1.42% | 13 |
|
|
2019
Q3 | $11.6M | Buy |
153,657
+83,909
| +120% | +$5.75M | 1.1% | 17 |
|
|
2019
Q2 | $5.07M | Buy |
+69,748
| New | +$5.48M | 0.45% | 44 |
|
|
2018
Q1 | – | Sell |
-87,746
| Closed | -$8.49M | – | 183 |
|
|
2017
Q4 | $8.49M | Buy |
+87,746
| New | +$8.27M | 0.39% | 57 |
|
|
2017
Q3 | – | Sell |
-205,733
| Closed | -$14.9M | – | 276 |
|
|
2017
Q2 | $14.9M | Sell |
205,733
-51,016
| -20% | -$3.43M | 0.65% | 32 |
|
|
2017
Q1 | $16.7M | Buy |
256,749
+251,359
| +4,663% | +$15.8M | 0.74% | 37 |
|
|
2016
Q4 | $338K | Sell |
5,390
-15,540
| -74% | -$949K | 0.01% | 256 |
|
|
2016
Q3 | $1.32M | Buy |
+20,930
| New | +$1.35M | 0.05% | 192 |
|
|
2015
Q3 | – | Sell |
-1,553,085
| Closed | -$104M | – | 148 |
|
|
2015
Q2 | $104M | Buy |
1,553,085
+109,214
| +8% | +$7.13M | 2.63% | 8 |
|
|
2015
Q1 | $84.5M | Buy |
+1,443,871
| New | +$87.2M | 2% | 14 |
|
Other funds holding ABBV
VCM
VPM
WBI Investments's ABBV Position: Q1 2026 in Review
WBI Investments sold out of AbbVie (ABBV) in Q1 2026, closing a stake of 3,017 shares — an estimated $689K sold.
WBI Investments first reported a position in ABBV in Q1 2015 and held it in 27 quarters. The position peaked at $104M in Q2 2015. 4,078 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- WBI Investments reported no remaining AbbVie position as of Q1 2026 after selling out during the quarter.
- WBI Investments sold 3,017 AbbVie shares in Q1 2026, an estimated $689K.
- WBI Investments first reported a position in AbbVie in Q1 2015 and held it in 27 quarters.
- WBI Investments's AbbVie position peaked at $104M in Q2 2015.
- 4,078 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on WBI Investments's 13F filing for Q1 2026, filed 11 May 2026.